This COVID-19 IgM/IgG Lateral Flow Assay is a lateral flow immunoassay used for in vitro qualitative detection of novel coronavirus (SARS-CoV-2) IgM/IgG antibodies in human whole blood, plasma, and serum specimens. Both IgM and IgG antibodies are tested using one test cassette, realizing convenient combination detection.

The COVID-19 IgG Lateral Flow Assay is a lateral flow immunoassay used for in vitro qualitative detection of Novel Coronavirus (SARS-CoV-2) IgG antibodies in human whole blood, plasma, and serum specimens. The specification can be chosen between cassette format and strip format, providing convenience of realizing IgG antibody rapid test.

The COVID-19 IgM Lateral Flow Assay is a lateral flow immunoassay used for in vitro qualitative detection of Novel Coronavirus (SARS-CoV-2) IgM antibodies in human whole blood, plasma, and serum specimens. The specification can be chosen between cassette format and strip format, providing convenience of realizing IgM antibody rapid test.

The COVID-19 IgG Antibody Detection Kit (CLIA) is a chemiluminescence immunoassay intended for in vitro quantitative detection of novel coronavirus (SARS-CoV-2) IgG antibodies in human serum samples. It is used in combination with our Full-Automatic Chemiluminescence Immunoassay System (FACIS-I), to simplify the operation procedure and obtain quantitative results.

The COVID-19 IgM Antibody Detection Kit (CLIA) is a chemiluminescence immunoassay intended for in vitro quantitative detection of novel coronavirus (SARS-CoV-2) IgM antibodies in human serum samples. It is used in combination with our Full-Automatic Chemiluminescence Immunoassay System (FACIS-I), to simplify the operation procedure and obtain quantitative results.